The authors examined the expression of myeloid antigens (MyAg): CDMb, CDI3, CD14,
CD15, and CD33 in 249 adults with lymphoid neoplasms using flow cytometric analysis. In …

We tested a total of 174 paraffin-embedded hematolymphoid neoplasias to determine
whether CD 10 can he specifically and sensitively detected on paraffin sections using …

We propose that 12E7 (CD99) expression, along with TdT, bcl2, and CD34 reactivity in
lymphoblastic lymphoma (LyL)/acute lymphoblastic leukemia (ALL), distinguishes this group …

Context.—CD10 was originally reported in non–T-cell lymphoblastic lymphomas/leukemias.
It has since been identified, however, in a minority of cases of T-lympho-blastic …

Current views about the origin of acute lymphoid leukemia (ALL) emphasize the importance
of maturation arrest at a precursor cell level. Recently, the CD22 antigen has been identified …

We report flow cytometric characterization of surface CD26 expression in 271 peripheral
blood samples from 154 patients evaluated for the presence of a T-cell lymphoproliferative …

We earlier identified a variant of CD30 (CD30v) that retains only the cytoplasmic region of
the authentic CD30. This variant is expressed in alveolar macrophages. CD30v can activate …

Acute lymphoblastic leukaemia/lymphoma is a malignant disorder derived from the clonal
proliferation of lymphoid precursor cells. Whether the tumour cells are of B‐or T‐cell type is …

The coexpression of CD5 and CD10 has previously been reported in cases of intermediate-
and high-grade lymphomas and in precursor B cells in normal or regenerating bone marrow …

CD20 is a 35-kDa protein that is expressed early in B-cell ontogeny and is lost during
terminal B-cell differentiation into plasma cells. It is thought to be B-cell–specific. However …